Italia markets close in 3 hours 56 minutes

Qiagen N.V. (0RLT.L)

LSE - LSE Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
46,94+1,24 (+2,71%)
In data: 05:45PM GMT. Mercato aperto.

Qiagen N.V.

Hulsterweg 82
Venlo 5912 PL
Netherlands
31 77 355 6600
https://www.qiagen.com

Settore/i
Settore
Impiegati a tempo pieno6.000

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Thierry BernardCEO, MD & Member of Management Board2,47MN/D1966
Dr. Roland SackersCFO, MD & Member of Management Board1,23MN/D1969
Mr. Antonio SantosSenior VP & Head of Global OperationsN/DN/DN/D
Mr. John GilardiVice President of Corporate Communications & Investor RelationsN/DN/DN/D
Ms. Stephany FosterSenior VP & Head of Human ResourcesN/DN/D1979
Dr. Thomas SchweinsSenior Vice President of Life Science Business AreaN/DN/DN/D
Dr. Thomas TheuringerSenior Director & Head of External CommunicationsN/DN/DN/D
Mr. Jean-Pascal ViolaSenior VP & Head of Molecular Diagnostics Business AreaN/DN/DN/D
Dr. Jonathan G. Sheldon Ph.D.Senior Vice President of Qiagen Digital Insights Business AreaN/DN/D1972
Mr. Thomas NeidertVice President of Global TreasuryN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2022 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in EUR.

Descrizione

QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV, as well as assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping, and gene regulation instruments and technologies; human ID and forensics assay consumables, including STR assays for human ID, and assays for food contamination; PCR instruments consist of digital PCR solutions; and developed and configured OEM consumables. Further, the company provides predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. The company was founded in 1986 and is headquartered in Venlo, the Netherlands.

Governance aziendale

L'ISS Governance QualityScore di Qiagen N.V. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.